Showing results (231-240 of 247) with videos related to

Sort By:
Pageof 25
Oncotarget|January 10, 2018
Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomasTareq A Juratli, Christian Thiede, Mara V A Koerner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2018
A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV InfectionJulia Hess, Kristian Unger, Cornelius Maihoefer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2014
Creating a data exchange strategy for radiotherapy research: towards federated databases and anonymised public datasetsTomas Skripcak, Claus Belka, Walter Bosch, et al.
The Pharmacogenomics Journal|June 18, 2020
ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapyMaja Guberina, Ali Sak, Christoph Pöttgen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2018
Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapyStefan Schmidt, Annett Linge, Alex Zwanenburg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 11, 2026
A tumor DNA-Methylome derived signature of Hypoxia Identifies HPV-negative head and neck cancer patients at risk for distant metastasis after postoperative radiochemotherapy (PORT-C)Bouchra Tawk, Gordana Halec, Katrin Rein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2016
Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROGAnnett Linge, Steffen Löck, Volker Gudziol, et al.
Cancers|June 24, 2022
A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORTShivaprasad Patil, Annett Linge, Hannah Hiepe, et al.
Scientific Reports|November 23, 2023
The DRESDEN PLATFORM is a research hub for ultra-high dose rate radiobiologyJosefine Metzkes-Ng, Florian-Emanuel Brack, Florian Kroll, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2016
HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)Annett Linge, Fabian Lohaus, Steffen Löck, et al.
Pageof 25